Education
About Us
Working with TipRanks
Follow Us
MeVis Medical Solutions (DE:M3V)
:M3V
RESEARCH TOOLSreports
Total Valuation
MeVis Medical Solutions has a market cap or net worth of €45.86M. The enterprise value is ―.
Market Cap€45.86M
Enterprise Value―
Share Statistics
MeVis Medical Solutions has 1,820,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,820,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MeVis Medical Solutions’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee173.42K
Profits Per Employee49.20K
Employee Count100
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of MeVis Medical Solutions is ―. MeVis Medical Solutions’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, MeVis Medical Solutions had revenue of 17.34M and earned 4.92M in profits. Earnings per share was 2.70.
Revenue17.34M
Gross Profit7.00M
Operating Income6.44M
Pretax Income5.03M
Net Income4.92M
EBITDA5.17M
Earnings Per Share (EPS)2.70
Cash Flow
In the last 12 months, operating cash flow was 96.63K and capital expenditures 0.00, giving a free cash flow of 96.63K billion.
Operating Cash Flow96.63K
Free Cash Flow96.63K
Free Cash Flow per Share0.05
Dividends & Yields
MeVis Medical Solutions pays an annual dividend of €0.949, resulting in a dividend yield of 3.71%
Dividend Per Share€0.949
Dividend Yield3.71%
Payout Ratio40.13%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.09
52-Week Price Change-1.75%
50-Day Moving Average25.77
200-Day Moving Average24.33
Relative Strength Index (RSI)36.33
Average Volume (3m)89.00
Important Dates
MeVis Medical Solutions upcoming earnings date is Feb 4, 2026, TBA Not Confirmed.
Last Earnings DateMay 27, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend DateMar 26, 2025
Financial Position
MeVis Medical Solutions as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, MeVis Medical Solutions has paid 114.18K in taxes.
Income Tax114.18K
Effective Tax Rate―
Enterprise Valuation
MeVis Medical Solutions EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
MeVis Medical Solutions has €4.87M in cash and marketable securities with €0.00 in debt, giving a net cash position of -€4.87M billion.
Cash & Marketable Securities€4.87M
Total Debt€0.00
Net Cash-€4.87M
Net Cash Per Share-€2.68
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for MeVis Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.14%
EPS Growth Forecast-7.29%